The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis (Q43984262)

28 November 2017

0 references

The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis (English)

1 reference

28 November 2017

1 reference

2

John P A Ioannidis

1 reference

28 November 2017

Emilios E Pakos

1

1 reference

PubMed ID

12879476

28 November 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

28 November 2017

1 reference

28 November 2017

98

1 reference

28 November 2017

3

1 reference

28 November 2017

581-589

1 reference

Prognostic factors in osteosarcoma: a critical review.

28 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Biochemistry of multidrug resistance mediated by the multidrug transporter

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Analysis of P-glycoprotein expression in osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

P-glycoprotein levels predict poor outcome in patients with osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

The co-expression of p53 protein and P-glycoprotein is correlated to a poor prognosis in osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Clinical significance of P-glycoprotein immunohistochemistry and doxorubicin binding assay in patients with osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Relationship between P-glycoprotein positivity, doxorubicin binding ability and histologic response to chemotherapy in osteosarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Quantitative synthesis in systematic reviews

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Expression of HER2/erbB-2 correlates with survival in osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Proteins expressed in osteosarcoma and serum levels as prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Quantitative analysis of multidrug resistance gene expression in human osteosarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Expression of the mdr1 gene in bone and soft tissue sarcomas of adult patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Expression of MDR1/P glycoprotein in human sarcomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Flow cytometric analysis of P-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Correlation of MDR1 gene expression with chemotherapy in neuroblastoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

P-glycoprotein expression at diagnosis may not be a primary mechanism of therapeutic failure in childhood rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Effect of P-glycoprotein expression on outcome in the Ewing family of tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

The expression of P-glycoprotein and multidrug resistance proteins 1 and 2 (MRP1 and MRP2) in human malignant mesothelioma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

P-glycoprotein, multidrug resistance and tumor progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Systematic reviews of evaluations of prognostic variables

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Statistical aspects of prognostic factor studies in oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

P53 Overexpression as an Indicator of Overall Survival and Response to Treatment in Osteosarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

ErbB2 expression is correlated with increased survival of patients with osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Microarrays--the 21st century divining rod?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11546

7 January 2021

Identifiers

DOI

10.1002/CNCR.11546

1 reference

28 November 2017

1 reference

PubMed ID

12879476